The estimated Net Worth of Andy Pasternak is at least $19 million dollars as of 17 January 2023. Mr Pasternak owns over 27,129 units of Horizon Therapeutics Plc stock worth over $6,552,109 and over the last 5 years he sold HZNP stock worth over $10,616,118. In addition, he makes $1,788,718 as Exec. VP & Chief Strategy Officer at Horizon Therapeutics Plc.
Mr has made over 14 trades of the Horizon Therapeutics Plc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 27,129 units of HZNP stock worth $3,066,391 on 17 January 2023.
The largest trade he's ever made was exercising 88,733 units of Horizon Therapeutics Plc stock on 30 December 2022 worth over $10,319,648. On average, Mr trades about 14,691 units every 38 days since 2019. As of 17 January 2023 he still owns at least 56,338 units of Horizon Therapeutics Plc stock.
You can see the complete history of Mr Pasternak stock trades at the bottom of the page.
Andy Pasternak is the Exec. VP & Chief Strategy Officer at Horizon Therapeutics Plc.
As the Exec. VP & Chief Strategy Officer of Horizon Therapeutics Plc, the total compensation of Mr Pasternak at Horizon Therapeutics Plc is $1,788,718. There are 6 executives at Horizon Therapeutics Plc getting paid more, with Timothy Walbert having the highest compensation of $13,873,200.
Mr Pasternak is 50, he's been the Exec. VP & Chief Strategy Officer of Horizon Therapeutics Plc since . There are 16 older and 7 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Andy's mailing address filed with the SEC is C/O HORIZON THERAPEUTICS PLC,, 70 ST. STEPHEN?S GREEN, DUBLIN, L2, D02 E2X4.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over $454,905,275 worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth $58,823,653 . The most active insiders traders include Jeff Himawan, Woodlands Health Ventures F... et Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of $12,248,018. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth $351,691.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: